Updates in the Medical and Surgical and Interventional Thyroid and Parathyroid Management

Updates in Medical and Surgical Thyroid and Parathyroid Management is planned and implemented interprofessionally by physicians, nurses, and physician associates.

This course is designed for these professions and may be of interest to speech pathologists and other clinicians specializing in endocrinology, surgery, and related services.

This activity is designed for endocrinology, surgery and primary care as well as otolaryngology, radiology, pathology, and nuclear medicine.

This CME course will provide education through lectures, case presentations, panel discussions, and question-and-answer sessions. The activity will highlight best practices across thyroid and parathyroid disease diagnosis, risk stratification, imaging, molecular testing, medical therapy, and surgical management.

The goal of this activity is to enhance knowledge, clinical skills, performance, and patient care.

1. Utilize a multidisciplinary approach (integrating endocrinology, surgery, and radiology) to customize treatment plans for patients with advanced or aggressive thyroid malignancies.
2. Identify and implement strategies to minimize perioperative complications in thyroid and parathyroid surgeries, including the optimal use of intraoperative nerve monitoring and postoperative calcium management.
3. Apply the latest consensus guidelines to differentiate which patients with lowrisk thyroid cancers are candidates for active surveillance versus surgical intervention.
4. Formulate evidencebased diagnostic and management algorithms for patients presenting with complex primary, secondary, or tertiary hyperparathyroidism.
5. Evaluate the clinical indications, benefits, and longterm outcomes of emerging interventional techniques, such as thermal ablation (RFAMWA), for benign and select malignant thyroid nodules.

This is a continuing medical education activity intended for healthcare providers.

Registration will be available until on Thursday, January 21, 2027, 12:00pm Central Time Zone.  After this time, please register on-site.

Residents & Fellows please email Lindsay Widaman [email protected] for information to register at no charge. Verification of your training status is requested. 

Fees include enrollment, continuing education credits, online educational materials, daytime self-parking (paid registrants only), continental breakfast, lunch, refreshment breaks.

Employees of industry (e.g., pharmaceutical and device companies), please email [email protected] for information regarding attendance at this course. Should you register at any other rate besides the Employee of Industry rate, your registration will be cancelled and an administrative fee of $50 will be charged. 

Registration/Payment Policy: Your full payment in advance completes your registration and ensures your enrollment in this course. To inquire about the availability to register on-site, please contact the CME office.

Cancellations: Registration fee, less $50 administrative charge, is refundable if cancellation is received in writing by emailing [email protected] by January 8, 2027. No refunds will be made on cancellation requests received after that date. Registration fees are not transferrable.

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

Minimum and Maximum Enrollments Have Been Established.

The cancellation cut-off dates and fees are specific to each course. Refer to the cancellation policy on the individual course page. Please send cancellation requests to [email protected].

WashU Medicine CME reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs incurred, such as non-refundable airline tickets or hotel penalties.

This meeting is conducted in accordance with the requirements of the Americans with Disabilities Act (ADA) and applicable regulations.
Individuals who require accommodations to participate are encouraged to submit a written request as early as possible, but no later than ten (10) business days prior to the seminar date, to allow sufficient time to arrange appropriate accommodations. Requests received after this deadline will be reviewed and a good faith effort will be made to provide reasonable accommodations to the extent feasible.

Suggested Hotel Accommodations: 

Doubletree by Hilton St. Louis Forest Park 
Adjacent to the conference center:
4550 Forest Park Ave., St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Ask for the Washington University Visitor rate.
Online at  Book your hotel Enter Code #3209101 under “special rate corporate”
By phone at 314-256-7777

Home 2 Suites by Hilton St. Louis/ Forest Park
920 S. Taylor Avenue, St. Louis, MO 63110
Make your hotel reservations directly with the hotel:
Online: Book your hotel
By phone: Reservations phone number is 314-531-4446

The Chase Park Plaza Royal Sonesta St. Louis
212 N Kingshighway Blvd, St. Louis, MO 63108
Make your hotel reservations directly with the hotel:
Online: Book your hotel
By phone: Reservations phone number is 314-633-3300

Please Note: Washington University is not responsible for airline, hotel reservations or any other travel expenses. Please confirm registration acceptance prior to purchase of nonrefundable or penalty airline tickets.

Transportation:
•    Taxis from the airport are approximately $40.
•    Uber and Lyft are also available.
•    MetroLink runs from the airport to the Medical Center
     (Central West End Station) for approximately $4.00

Washington University School of Medicine in St. Louis School of Medicine adheres to ACCME Criteria, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and their commercial relationships will be made prior to the activity.

Mitigation of Relevant Financial Relationships

Washington University School of Medicine in St. Louis adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including Faculty, planners, reviewers, or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Richard A Harbison, MD
Assistant Professor
Barnes-Jewish Hospital
Saint Louis, MO

Co-Director, Faculty

Nothing to disclose

Sina Jasim, MD, MPH
Washington university in St. Louis
Saint Louis, MO

Course Director, Faculty

Nothing to disclose

Douglas R. Adkins, MD
WashU Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-Adcendo ApS (*)|Other relevant financial or material interests-Asgard Therapeutics AB (*)|Other relevant financial or material interests-Astra Zeneca (*)|Other relevant financial or material interests-Bicara Therapeutics (*)|Other relevant financial or material interests-Black Canyon Bio Inc (*)|Other relevant financial or material interests-Boehringer Ingelheim Pharmaceuticals Inc (*)|Other relevant financial or material interests-Cue Biopharma Inc|Other relevant financial or material interests-Genmab A/S (*)|Other relevant financial or material interests-glaxo smith kline (*)|Other relevant financial or material interests-Immunitas Therapeutics (*)|Other relevant financial or material interests-Inhibrx Inc (*)|Other relevant financial or material interests-Johnson & Johnson (*)|Other relevant financial or material interests-Kura Oncology|Other relevant financial or material interests-Merck & Co.|Other relevant financial or material interests-Merus (*)|Other relevant financial or material interests-Purple Biotech Ltd (*)|Other relevant financial or material interests-Pyxis Oncology, Inc (*)|Other relevant financial or material interests-Regeneron Pharmaceuticals (*)|Other relevant financial or material interests-Tubulis GmbH (*)|Grant or research support-Merus|Grant or research support-Kura Oncology|Grant or research support-GlaxoSmithKline/GSK|Grant or research support-Daiichi Sankyo Inc|Grant or research support-Takeda Development Center Americas Inc|Grant or research support-Tempus|Grant or research support-Coherus Oncology Inc.|Grant or research support-Adlai Nortye Ltd|Grant or research support-Merck Sharp & Dohme Corp|Grant or research support-Seagen Inc|Grant or research support-Janssen Research & Development LLC|Grant or research support-Immutep Limited|Grant or research support-Lilly USA, LLC|Grant or research support-Cue Biopharma Inc|Grant or research support-Sun Pharma Advanced Research Company Ltd/SPARC|Grant or research support-Pfizer Inc|Grant or research support-AVEO Pharmaceuticals, Inc.|Grant or research support-Bristol Myers Squibb Co/BMS|Grant or research support-Vaccinex, Inc.|Grant or research support-Tizona Therapeutics|Grant or research support-Celex Oncology Innovations Limited|Grant or research support-Rgenta Therapeutics, Inc.|Grant or research support-Genmab A/S|Grant or research support-Inhibrx Inc|Grant or research support-Janux Therapeutics|Grant or research support-Xilio Therapeutics|Grant or research support-Immunogenesis|Grant or research support-AstraZeneca AB (Sweden)|Grant or research support-Gilead Sciences Inc|Grant or research support-Exelixis Inc|Grant or research support-Bicara Therapeutics

Huda Al-Bahadili, MD
, MO

Faculty

Consulting Fee-SANOFI|Consulting Fee-IMVT Corporation

Taylor C Brown, MD
Associate Professor of Surgery
Barnes Jewish Hospital/Washington University School of Medicine
St. Louis, MO

Faculty

Nothing to disclose

Steven Couch, MD
Wash u
St. Louis, MO

Faculty

Rowena Delos Santos, MD
Washington University
St. Louis, MO

Faculty

Other relevant financial or material interests|Grant or research support-CareDx Inc

Stephanie Markovina, MD
St. Louis, MO

Faculty

John A Olson Jr., MD
Chair, Department of Surgery William K. Bixby Professor of Surgery
Washington University School of Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests|Grant or research support-Leidos

Nikhil Rammohan, MD
Washington University School of Medicine
Saint Louis, MO

Faculty

Nothing to disclose

Maamoun Salam, MD
Professor of Medicine Medical Director, Inpatient Diabetes, Barnes-Jewish Hospital
WashU Medicine
St. Louis, MO

Faculty

Other relevant financial or material interests-Reach Market Research (*)|Grant or research support-Neurocrine Biosciences Inc|Grant or research support-Crinetics Pharmaceuticals|Grant or research support-MBX Biosciences, Inc|Grant or research support-Bayer HealthCare Pharmaceuticals

Naga M. Yalla, MD
Associate Professor of Medicine Endocrinology, Metabolism and Lipid Research
WashU Medicine
St. Louis, MO

Faculty

Nothing to disclose

Latosha Aytch, RN
WashU School of Medicine
Saint Louis, MO

Faculty, Nurse Planner

Nothing to disclose

William E. Gillanders, MD
Professor
Washington University
St. Louis, MO

Faculty, Other Planning Committee Member

Nothing to disclose

Theresa Puljic, MBA
Business Director
Washington University in St Louis
ST. LOUIS, MO

Faculty, Other Planning Committee Member

Nothing to disclose

Isabelle Reed South, PA-C
Physician Assistant
WashU Medicine
St. Louis, MO

Faculty, Other Planning Committee Member

Nothing to disclose

Amy E. Riek, MD, MSCI
Professor of Medicine
WashU Medicine
St. Louis, MO

Faculty, Peer Reviewer

Nothing to disclose

Brandy Fleming, Other, Assistant to Chief DOM
Assistant to the Chief
Washington University
ST. LOUIS, MO

Other Planning Committee Member

Nothing to disclose